Salubris Biotherapeutics

View the org chart displaying its 8 main executives

Most searched biographies at Salubris Biotherapeutics

• Sam Murphy, Chief Executive Officer
• Shalabh Singhal, Chief Medical Officer
• Jijun Dong, Chief Scientific Officer

Create your alert
to follow the executive moves at Salubris Biotherapeutics.

Salubris Biotherapeutics has 2,290 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Aardvark Therapeutics has just announced a $85 Million fundraising (posted on May 12 2024).
• Bluejay Therapeutics has just announced a $182 Million fundraising (posted on May 12 2024).
• Delphia Therapeutics has just announced a $67 Million fundraising (posted on May 7 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Carl Gordon - Director at Adicet Bio
• Vik Bajaj - Director at Interline Therapeutics

Learn more about the Biotechnology industry >

Press releases by Salubris Biotherapeutics

• News - Salubris Bio

Social media about Salubris Biotherapeutics

• Salubris Biotherapeutics on Wikipedia, Google News & Yahoo Finance
• Salubris Biotherapeutics on LinkedIn, Twitter & YouTube

Contact by email its executives including Sam Murphy

Call Salubris Biotherapeutics at +1 240...

View the org chart

Register to receive your alert

Report an error